Who
Gerald T. Proehl
President, Chairman, CEO
Company insider
Files Form 4 as: President, Chairman, CEO, Dermata Therapeutics; Director, Tenax Therapeutics; Director, Sophiris Bio; Director, FF EAI Robotics Ecosystem; Director, Auspex Pharmaceuticals; President & CEO, Santarus; Director, Depomed.
In numbers
- Trades disclosed
- 267
- Buys
- 11
- Sells
- 19
- Bought
- $578K
- Sold
- $12.1M
- Companies
- 7
- Companies where not an officer
- 5
- First trade
- 21 Sep 2005
- Last trade
- 16 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata TherapeuticsBiotechnology | SEC FORM 4 Code A | —170,068 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,360,544 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,360,544 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,360,544 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,360,544 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —170,068 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —170,068 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,360,544 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —170,068 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —170,068 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,360,544 | filing |
| 16 Aug 2026filed 18 Aug 2026 | DRMA Dermata TherapeuticsBiotechnology | SEC FORM 4 Code A | —170,068 | filing |
| 9 Jan 2026filed 13 Jan 2026 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 9 Jan 2026filed 13 Jan 2026 | TENX Tenax Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 23 Dec 2025filed 29 Dec 2025 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —490,196 | filing |
| 23 Dec 2025filed 29 Dec 2025 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —490,196 | filing |
| 23 Dec 2025filed 29 Dec 2025 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —122,549 | filing |
| 23 Dec 2025filed 29 Dec 2025 | DRMA Dermata Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —122,549 | filing |
News
FF EAI Robotics Ecosystem Inc. to Present at the 2026 ThinkEquity ConferenceFFR · prnewswire.com · 8 Oct 2026
0 headlines in the last 90 days name Gerald T. Proehl; 1 article from the last 14 days about the 3 companies they traded most, at most three about any one of them.